Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07626268

COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)- A Pilot Randomized Controlled Trial

The goal of this clinical trial is to learn whether different ways of providing information and follow-up support after acute kidney injury, also called AKI, can improve care transitions for adults being discharged from the hospital. AKI is a sudden decrease in kidney function that can occur during a hospital stay.

The main questions this study aims to answer are:

* Does an AKI discharge summary template improve communication about AKI after hospital discharge? * Does a chat-based educational messaging program improve patient understanding of AKI and support follow-up care after hospital discharge? * Researchers will compare usual care, an AKI discharge summary template, a chat-based educational messaging program, and the combination of the discharge summary template plus chat-based messaging.

Researchers will compare four groups:

* Usual care * An AKI discharge summary template * A chat-based educational messaging program * Both the AKI discharge summary template and the chat-based educational messaging program

Participants will complete questionnaires at the start of the study and about 4 weeks after hospital discharge. Participants will also receive a brief phone call about 3 months after discharge, and the research team will review their medical record for information about follow-up care, lab testing, emergency department visits, and hospital readmissions.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Acute kidney injury, also called AKI, is a common complication during hospitalization and is associated with increased risk of poor outcomes after discharge, including incomplete kidney recovery, medication-related safety concerns, emergency department visits, and hospital readmissions. Despite these risks, information about AKI and recommended follow-up care may not always be communicated clearly to patients or outpatient clinicians during the transition from hospital to home.

This pilot randomized clinical trial will evaluate the feasibility and preliminary effects of two care transition strategies for adults hospitalized with AKI. The strategies include an AKI discharge summary template designed to improve communication with outpatient clinicians, and a chat-based educational messaging program designed to provide patients with AKI-related information after discharge.

Participants will be assigned to one of four study groups: usual care, the AKI discharge summary template, the chat-based educational messaging program, or both the discharge summary template and chat-based messaging. The study will assess whether these strategies are feasible to deliver and acceptable to participants, and whether they improve patient knowledge, perceived preparedness, communication about AKI, and completion of recommended follow-up care after hospital discharge.

Participants will complete study questionnaires and allow the research team to review their medical records for information related to kidney function monitoring, follow-up care, emergency department visits, and hospital readmissions. The results of this pilot study will help inform the design of a larger future trial to improve care transitions for patients recovering from AKI.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Hospitalized with Stage 2 or Stage 3 acute kidney injury
  • Kidney function has not returned to baseline at the time of hospital discharge
  • Able to communicate in English
  • Able to provide informed consent
  • Willing and able to participate in study procedures independently or with assistance from a patient-designated care partner

Exclusion criteria

  • Acute kidney injury requiring ongoing dialysis at the time of hospital discharge
  • End-stage kidney disease
  • Kidney transplant recipient
  • Currently pregnant
  • Documented cognitive impairment that precludes informed consent
  • Receiving hospice or comfort-focused end-of-life care

Treatment and study plan

AKI Discharge Summary Template

Behavioral

The AKI discharge summary template provides structured AKI-related information for the hospital discharge summary, including information about the AKI episode and recommended follow-up care. The template is intended to improve communication during the transition from hospital to outpatient care.

Chat-Based Educational Messaging Program

Behavioral

The chat-based educational messaging program provides AKI-related educational messages after hospital discharge. Messages are delivered through a secure web-based chat-style interface and are designed to support patient understanding of AKI, post-discharge follow-up, and kidney-related care after hospitalization.

Primary outcomes

  1. Feasibility: Eligible patient enrollment

    Time frame: Enrollment period

    Percentage of eligible patients enrolled among those approached.

  2. Feasibility: Participant retention

    Time frame: Baseline to 3 months after discharge

    Percentage of enrolled participants who complete the follow-up assessment.

  3. Feasibility: Successful delivery of assigned intervention components

    Time frame: Hospital discharge through 4 weeks after discharge

    Percentage of participants assigned to an intervention arm who receive the assigned intervention component or components as intended, including the AKI discharge summary template and/or chat-based educational messaging program.

Secondary outcomes

  1. AKI Knowledge Score

    Time frame: 4 weeks after hospital discharge

    Participant AKI knowledge score measured using a study questionnaire.

  2. Patient experience during care transitions

    Time frame: 4 weeks after hospital discharge

    Patient-reported care transition experience measured using a validated transition-of-care instrument, such as the Care Transitions Measure-15.

  3. Self-management behaviors related to kidney health

    Time frame: 4 weeks after hospital discharge

    Participant-reported self-management behaviors related to kidney health after hospital discharge, assessed using a study questionnaire.

  4. Adherence to outpatient follow-up appointments

    Time frame: 4 weeks after hospital discharge, and 3 months after hospital discharge

    Percentage of participants who complete follow-up with a primary care provider or specialist after hospital discharge, assessed by participant report and/or medical record review.

  5. Patient-reported discussion of AKI with outpatient provider

    Time frame: 4 weeks after hospital discharge

    Percentage of participants who report discussing AKI or kidney-related follow-up needs with an outpatient provider after hospital discharge.

Other outcomes

  1. Hospital readmission

    Time frame: Within 4 weeks and within 3 months after hospital discharge

    Percentage of participants readmitted to the hospital after discharge from the index hospitalization.

  2. Kidney function trajectory after discharge

    Time frame: Within 4 weeks and within 3 months after hospital discharge

    Kidney function status after hospital discharge, categorized as improved, stable, worsened, or requiring dialysis, based on available laboratory and clinical data.

Study contacts

Contact information is provided by the study sponsor or research team.

Farwa Batool, MPH

CONTACT

[email protected]

Jia Hwei Ng, MD, MSCE

CONTACT

[email protected]

516-465-8200

Sponsors and collaborators

Lead sponsor

Northwell Health

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Official study title

CONNECT-AKI: COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury - A Pilot Randomized Controlled Trial

Acronym: CONNECT-AKI

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jun 4, 2026
Registry last updated
Jun 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.